NCT03221829

Brief Summary

The aim of the study was to evaluate the safety and effectiveness of spinal anesthesia among elderly patients The basic methods for diagnosis and management of bladder cancer include endoscopic procedures (cystoscopy, trans-urethral resection of bladder tumour TURBT). The age of most patients is above 60, which increases the risk of complications during the perioperative period. Usually the leading anaesthesia method in TURBT procedures is regional, mainly spinal, anaesthesia. Although the prevalence of regional upon general anaesthesia is questioned, certain positive aspects of regional anaesthesia are indisputable. Maintaining logical communication with a patient during the procedure enables early diagnosis of complications (TUR syndrome, bladder perforation). Undeniably, regional anaesthesia ensures the best pain management in the early post-operative period. The simplicity of performing an efficacious spinal block and its cost-effectiveness are additional factors, which have contributed to the acknowledgement of the method as the standard of anaesthesia for transurethral procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 6, 2017

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 19, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
Last Updated

July 19, 2017

Status Verified

July 1, 2017

Enrollment Period

6 months

First QC Date

July 13, 2017

Last Update Submit

July 14, 2017

Conditions

Keywords

spinal anaesthesiaelderly patientstransurethral resection of bladder tumour

Outcome Measures

Primary Outcomes (1)

  • The effectiveness of spinal anaesthesia for TURBT evaluated by a number of participants that had the procedure done, without the need of conversion to general anaesthesia .

    The investigator evaluates whether the procedure could be completely performed under spinal anesthesia

    6 months

Secondary Outcomes (4)

  • The influence of the bupivacaine spinal dose on bradycardia evaluated by a heart rate measurements

    6 months

  • The influence of the bupivacaine dose on hypotension evaluated by the non-invasive blood pressure measurements

    6 months

  • Experienced and non-experienced anesthetist does it influence the bupivacaine dose

    6 months

  • Experienced and non-experienced anesthetist does it influence the spinal anaesthesia success

    6 months

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients that have TURBT procedure under spinal anaesthesia in the Urology Departament (Medical University of Warsaw) 2007-2017

You may qualify if:

  • TURBT procedure
  • spinal anaesthesia
  • age over 60

You may not qualify if:

  • general anaesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw

Warsaw, 02-005, Poland

RECRUITING

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Central Study Contacts

Karolina Dobronska, MD, PhD

CONTACT

Lidia I Jureczko, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD. PhD.

Study Record Dates

First Submitted

July 13, 2017

First Posted

July 19, 2017

Study Start

July 6, 2017

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

July 19, 2017

Record last verified: 2017-07

Locations